Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics

Moisi, Mădălina Ioana; Rus, Marius; Bungău, Simona; Zaha, Dana Carmen; Uivaroșan, Diana; Frățilă, Ovidiu; Ţiţ, Delia Mirela; Endres, Laura; Nistor-Cseppentö, Delia Carmen; Popescu, Mircea Ioachim

doi:10.3390/medicina56030118

Cited by 34 publications

(30 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Another review reported that the incidence of tuberculous pericarditis is increasing in Africa, as a result of the HIV epidemic [6]. Pericardial effusion can be secondary to noninfectious diseases, such as autoimmune diseases (systemic lupus erythematosus, rheumatoid arthritis, Sjogren syndrome, sarcoidosis), primary tumors (pericardial mesothelioma) or secondary tumors (most common lung cancer and breast cancer, lymphomas and melanoma), acute myocardial infarction (Dressler syndrome), chronic renal failure [8], hypothyroidism (myxedema), mediastinal radiation, direct injury (penetrating thoracic injury), drugs (especially procainamide, hydralazine), and after an invasive cardiac procedure (post-pericardiotomy syndrome), or it may have hemodynamic causes (heart failure, pulmonary hypertension) [3]. In a study that enrolled 114 patients with neoplasia, pericardial diseases were diagnosed in 18% of cases throughout the monitoring period [9].…”

Section: Etiology Of Pericardial Effusionmentioning

confidence: 99%

Diagnosis and management of pericardial effusion

Manea¹,

Bratu²,

Bacalbaşa³

et al. 2020

JMMS

View full text Add to dashboard Cite

Pericardial effusion is a common pathology in clinical practice. The etiology of pericardial effusion is diverse, from infectious diseases, malignancies, autoimmune diseases, chronic renal failure, to drug-related or after an invasive cardiac intervention. Clinical presentation of pericardial effusion is variable, depending on the volume of the fluid and the rate of accumulation. Clinical manifestations are dramatic if the pericardial fluid accumulates rapidly. Classical symptoms in pericardial effusion include pleuritic chest pain associated with dyspnea. In case of cardiac tamponade, orthopnea, jugular venous distension, pulsus paradoxus, hypotension, and shock appear. Transthoracic echocardiography is the gold standard investigation for the diagnosis of pericardial effusions. The echocardiographic signs of cardiac tamponade are represented by the collapse of the right atrium and right ventricle, respiratory alteration of mitral and tricuspid flow, and changes of the inferior vena cava. Management of pericardial effusion is guided by several factors, including hemodynamic impact and etiology. Pericardiocentesis guided by echocardiography is a life-saving procedure in cases of large pericardial effusions and cardiac tamponade. This is a review of the diagnosis and treatment of pericardial effusion.

show abstract

Section: Etiology Of Pericardial Effusionmentioning

confidence: 99%

Diagnosis and management of pericardial effusion

Manea¹,

Bratu²,

Bacalbaşa³

et al. 2020

JMMS

View full text Add to dashboard Cite

show abstract

“…According to a report by the Chinese Center for Disease Control and Prevention, there are three degrees of damage induced by infection with SARS-CoV-2, listed in Table 3 [16,27]. In most cases, the damage caused by this infection is not severe and death generally occurs among patients who have significant comorbidities (cardiovascular disease [28,29], diabetes [30,31], chronic respiratory disease, hypertension [32,33], cancer, etc).…”

Section: Diagnosismentioning

confidence: 99%

The infection with new coronavirus SARS-CoV-2

Gheorghe¹,

Gheorghe²,

Ceobanu³

et al. 2020

Ro J Med Pract.

View full text Add to dashboard Cite

The new coronavirus, SARS-CoV-2, first identified in humans in Wuhan Province, China, in December 2019, has spread rapidly throughout the world, causing World Health Organization (WHO) to declare it a pandemic infection. This pathogenic agent belongs to the genus beta-coronavirus, alongside SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome). The large number of infected patients is mainly due to the modality of transmission, through respiratory droplets. The most common manifestation of the disease/infection COVID-19 is pneumonia, as there are not any specific clinical manifestations that differentiate this disease from other respiratory viral infections. The confirmation of COVID-19 is done by RT-PCR (Real-Time Polymerase Chain Reaction) of respiratory specimens. In most cases, the damage induced by this infection is not severe, and death occurs most frequently among older patients or with significant comorbidities. To control this pandemic infection, measures such as self-isolation at home or quarantine are recommended. Given both the large number of infected patients, as well as the large number of deaths, it is imperative to conduct studies that identify effective therapeutic measures.

show abstract

“…Depending on the value of GFR and albuminuria, CKD is divided into five stages. Its importance is given by the fact that all CKD stages are associated with the increase of the risk of cardiovascular morbidity, the decrease of the quality of life and premature deaths, representing the ninth cause of death in the USA 8 . Most often, between CKD and cardiovascular pathology (especially the presence of hypertension) there is a close relationship, so CKD contributes as an accelerator of CVD and the CVD deteriorates faster the GFR, accelerating CKD progression to stage 5, the final stage of CKD.…”

Section: Introductionmentioning

confidence: 99%

“…Most often, between CKD and cardiovascular pathology (especially the presence of hypertension) there is a close relationship, so CKD contributes as an accelerator of CVD and the CVD deteriorates faster the GFR, accelerating CKD progression to stage 5, the final stage of CKD. The most common causes of CKD remain high blood pressure, diabetes, atherosclerosis and glomerulonephritis 8 . Patients with CKD stage 1-3 are usually asymptomatic, clinical manifestations begin to appear with reduced GFR, especially in stages 4-5, when hydro-electrolytic disorders (most common hyperkalemia), endocrine disorders (including secondary anemia), metabolic acidosis, caloric protein malnutrition occur, all with a negative impact both on the general condition of the patient and the GFR.…”

Section: Introductionmentioning

confidence: 99%

“…DM is considered nowadays a global health problem, recent data claiming that in 2017 there were over 450 million diabetic patients; also, it is estimated that in the future the incidence of this disease will rapidly increase 10 , due to some relevant factors included in patient's life style: eating habits, level of physical activity, alcohol consumption, tobacco, and/or drugs, etc. The importance of this condition is based on the risk of premature death, representing itself an independent cardiovascular risk factor for CKD and many other complications (micro and macrovascular), that not only strongly influence the quality of life but also the morbidity and mortality (increasing by 2-4 times the cardiovascular mortality) 8,11 .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Extrahepatic blood supply to hepatocellular carcinoma – a pictorial essay

Baidog¹,

Bungău²,

Behl³

et al. 2020

Arch Balk Med Union

View full text Add to dashboard Cite

Interrélation entre l'hyperuricémie, le syndrome métabolique et la maladie rénale chronique chez les patients avec diabète sucré de type 2 Introduction. L'hyperuricémie est un puissant prédicteur d'un état métabolique altéré. Il existe des interrelations complexes entre l'hyperuricémie, le diabète sucré de type 2, le syndrome métabolique et l'insuffisance rénale chronique. L'objectif de l'étude était d'étudier l'impact de l'hyperuricémie sur la prévalence de la SEP et de la fonction glomérulaire chez les patients atteints de diabète sucré de type 2. Matériaux et méthodes. Cette étude rétrospective a inclus 300 patients atteints de diabète sucré de type ABSTRACT Introduction. Hyperuricemia is a strong predictor of an altered metabolic status. There are complex interrelationships between hyperuricemia, type 2 diabetes mellitus (T2DM), metabolic syndrome (MS) and chronic kidney disease (CKD). The objective of the study was to investigate the impact of hyperuricemia on the prevalence of MS and glomerular function in patients with T2DM. Materials and methods. This retrospective study included 300 patients with T2DM, hospitalized for one day in the diabetes clinic, between 01.01.2016-31.12.2018; all the data used for the analysis were obtained from the medical records. Results. The prevalence of hyperuricemia was 46%. MS was identified in 88.41% patients with

show abstract

Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics

Cited by 34 publications

References 42 publications

Diagnosis and management of pericardial effusion

Diagnosis and management of pericardial effusion

The infection with new coronavirus SARS-CoV-2

Extrahepatic blood supply to hepatocellular carcinoma – a pictorial essay

Contact Info

Product

Resources

About